Atıf İçin Kopyala
ÖZKÜTÜK A. A., Ergon C., Metin D. Y., Yucesoy M., Polat S. H.
JOURNAL OF CHEMOTHERAPY, cilt.20, sa.1, ss.87-92, 2008 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
20
Sayı:
1
-
Basım Tarihi:
2008
-
Doi Numarası:
10.1179/joc.2008.20.1.87
-
Dergi Adı:
JOURNAL OF CHEMOTHERAPY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.87-92
-
Anahtar Kelimeler:
Aspergillus spp., antifungal susceptibility testing, CLSI M38-A, E-test, disk diffusion, amphotericin B, itraconazole, voriconazole, IN-VITRO SUSCEPTIBILITY, ANTIFUNGAL AGENTS, CANDIDA SPP., ETEST METHOD, POSACONAZOLE, FUMIGATUS, RESISTANCE, AGAR
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
In response to the recent increase in Aspergillus infections, new antifungal agents have become available accompanied by studies on antifungal susceptibility tests for epidemiological follow-up. The aim of this study was to compare the efficacy of Clinical Laboratory Standards Institute (CLSI) M 38-A broth microdilution test with the disk diffusion and E-test in determining the susceptibility of Aspergillus spp. to amphotericin B, itraconazole and voriconazole.